Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Protein Arginine Methyltransferase 7 (PRMT7) Peptide

PRMT7 Reactivity: Mammalian Host: Synthetic BP, WB, IHC
Catalog No. ABIN938617

Quick Overview for Protein Arginine Methyltransferase 7 (PRMT7) Peptide (ABIN938617)

Target

PRMT7 (Protein Arginine Methyltransferase 7 (PRMT7))

Origin

Mammalian

Source

  • 5
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Peptide Type

    Synthetic

    Sequence

    GEINDQDRTD HYAQALRTVL LPGSVCLCVS DGSLLSMLAH HLGAEQVFTV

    Characteristics

    A synthetic peptide for use as a blocking control in assays to test for specificity of Prmt7 antibody,
    Alternative Names: Prmt7 control peptide, Prmt7 antibody Blocking Peptide, Anti-Prmt7 Blocking Peptide, protein arginine N-methyltransferase 7 Blocking Peptide, 4933402B05Rik Blocking Peptide, BC006705 Blocking Peptide, MGC7929 Blocking Peptide, Prmt7, Prmt-7, Prmt 7, Prmt-7 Blocking Peptide, Prmt 7 Blocking Peptide
  • Application Notes

    Optimal conditions should be determined by the investigator

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.

    Buffer

    PBS

    Handling Advice

    Avoid repeated freeze/thaw cycles.

    Storage

    -20 °C

    Storage Comment

    Store at -20 °C long term.
  • Target

    PRMT7 (Protein Arginine Methyltransferase 7 (PRMT7))

    Background

    Prmt7 is a arginine methyltransferase that can both catalyze the formation of omega-N monomethylarginine (MMA) and symmetrical dimethylarginine (sDMA), with a preference for the formation of MMA. It specifically mediates the symmetrical dimethylation of arginine residues in the small nuclear ribonucleoproteins Sm D1 (SNRPD1) and Sm D3 (SNRPD3), such methylation being required for the assembly and biogenesis of snRNP core particles.

    Molecular Weight

    78 kDa
You are here:
Chat with us!